By component, the Healthcare was the dominant sub-segment with major market share in 2022 in the LAMEA Digital Immune System Market. This sub-segment is likely to follow same momentum by the end of 2032.
End Use is projected as the most lucrative segment. The report provides insights based on the key determinants of the market, including drivers and challenges along with their relative impact on the regional and country level.
